English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background: Interaction between programmed cell death ligand-1 (PD-L1) and its receptor PD-1 is a major inhibitory pathway in maintaining an immunosuppressive tumor microenvironment. The expression of PD-L1 in various solid tumors is proposed to function in preventing T-cell mediated tumor killing and activating tumor-suppressive cell populations through different mechanisms. B-cell Lymphoma-2 (Bcl-2) is a key anti-apoptotic protein that has been described as a mediator of cancer progression. The expression of PD-L1 on the activated T-cells supports their survival. Objectives:Evaluate the expression of PD-1, PD-L1 in relation to apoptosis among patients with breast cancer. PD-1, PD-L1 and Bcl-2 l were correlated with each other and with the clinicopathological features of the disease. Patients and Methods: This study was conducted on 55 breast cancer patients with different stages of the disease.20 healthy individuals were included as a control group. Patient groups were divided into an early and advanced-stage of the disease. The percentage of PD-1 and PDL-1 were measured in blood samples using flowcytometry. Quantitative detection of Bcl-2 protein was assessed using an enzyme linked immunosorbent assay. Results: PD-L1 expression was significantly associated with tumor grade, lymph node involvement, tumor size, vascular invasion and hormonal receptors. PD-1 positivity was significantly associated with lymph node involvement. A significant negative correlation was found between serum Bcl-2 and early-stage and lymph node involvement. However, a significant positive correlation existed between serum Bcl-2 and PD-L1+. Conclusions: The correlation between PD-L1+ expression and serum Bcl-2 concentration may highlight the role of apoptotic machinery in the pathogenesis of breast cancer.

international journal of cancer and biomedical research

The Programmed Death-1 Receptor, Programmed Death-1 Ligand (PD-1/PD-L1) and Apoptosis in Breast Cancer Patients: A potential Mechanism of Immune Escape